Completed PHASE4 INTERVENTIONAL NCT00451828

Cholesterol and Pharmacogenetic Study (CAP)

Sponsor: Cedars-Sinai Medical Center

Conditions Cardiovascular Disease Coronary Heart Disease Hypercholesterolemia Hyperlipidemia

Interventions Simvastatin

Updated 8 times since 2017 Last updated: Oct 4, 2011 Started: Mar 31, 2002 Primary completion: Oct 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cardiovascular Disease and Coronary Heart Disease, this trial is completed. The trial is conducted by Cedars-Sinai Medical Center and has accumulated 8 data snapshots since 2002. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Sep 2020 — Jan 2021 [monthly]

Completed PHASE4
Aug 2019 — Sep 2020 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Aug 2019 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Mar 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cedars-Sinai Medical Center
Duke University
National Heart, Lung, and Blood Institute (NHLBI)
San Francisco General Hospital
UCSF Benioff Children's Hospital Oakland
University of California, Los Angeles
University of Washington

Data source: UCSF Benioff Children's Hospital Oakland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States